| Literature DB >> 19155300 |
J Keith Killian1, Sven Bilke, Sean Davis, Robert L Walker, M Scott Killian, Erich B Jaeger, Yidong Chen, Jason Hipp, Stefania Pittaluga, Mark Raffeld, Robert Cornelison, William I Smith, Marina Bibikova, Jian-Bing Fan, Michael R Emmert-Buck, Elaine S Jaffe, Paul S Meltzer.
Abstract
Emerging technologies allow broad profiling of the cancer genome for differential DNA methylation relative to benign cells. Herein, bisulfite-modified DNA from lymph nodes with either reactive hyperplasia or follicular lymphoma (FL) were analyzed using a commercial C/UpG genotyping assay. Two hundred fifty-nine differentially methylated targets (DMT) distributed among 183 unique genes were identified in FL. Comparison of matched formalin-fixed, paraffin-embedded and frozen surgical pathology replicates showed the complete preservation of the cancer methylome among differently archived tissue specimens. Analysis of the DMT profile is consistent with a pervasive epigenomic remodeling process in FL that affects predominantly nonlymphoid genes.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19155300 PMCID: PMC7213763 DOI: 10.1158/0008-5472.CAN-08-2984
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701